The study on development of the technology of the syrup with the hepatotropic and choleretic action
Keywords:syrup, technology, hepatotropic and choleretic drugs, aqueous extract of the medicinal plant raw material
AbstractAmong the most dangerous diseases of the hepatobiliary system (GBS), and gall bladder there are chronic and acute viral hepatites, cirrhosis and fibrosis of the liver, cholestases, cholecystitis, fatty liver, etc. Despite the large number of diseases, as well symptoms and syndromes accompanied them the main pathogenetic factors are destruction of hepatocytes, formation and outflow of the bile. Due to the combined composition the herbal drug developed in the form of syrup has a complex action. The problem of its administration in patients with diabetes mellitus and obesity is solved by using sorbitol and a natural sweetener – the herb of stevia. Development of the technology for “Cholophyt” syrup is based on physicochemical and technological properties of ingredients included in its composition. The main principle of the technology was to obtain the base of the syrup – the sorbitol concentrate with a preservative mixed with the concentrated combined aqueous extract. The critical stages of the technological process such as duration and the temperature of heating, the rate of mixing, the time and conditions of dissolution of ingredients have been determined.
Дроговоз С.М., Щекина Е.Г, Ушакова А.А. // Провизор. – 2008. – №8.
Камаева С.С., Лаврентьев Т.С., Меркурьева Г.Ю. // Матер. Рос. науч.-практ. конф. «Актуальные вопросы повышения качества последипломной подготовки фармацевтических кадров». – Казань, КГМУ, 2013. – С. 56-58.
Федорова О.С., Пантгахин А.В. // Актуальные проблемы фармацевтической науки и практики: сб. научн. тр. Сев.-Осет. гос. ун-т им. К.Л.Хетагурова. – Владикавказ: Изд-во СОГУ, 2010. – С. 111-114.
Шаталова Т.А., Айрапетова А.Ю., Мыкоц Л.П. и др. // Современные проблемы науки и образования. – 2013. – №4. Режим доступа к журналу: www. science-education. ru / 110-9785
Юскеева В.С. / Бюллетень медицинских интернет-конференций. – 2013. – Т. 3, вып. 3.
Barbeskar C., Geeverghese R. // World J. Pharmac. Res. – 2015. – №4. – Р. 462-484.
Fanigliulo A., De Filippis P., Curcuruto O. et al. // Pharm. Biomed. Anal. – 2015. – Nov. 10; 115. – P. 39-47.
Kaushik A., Chauhan V., Sudha D. // Eur. J. of Pharmac. and Med. Res. – 2016. – №3(5). – Р. 517-522.
Copyright (c) 2016 National University of Pharmacy
This work is licensed under a Creative Commons Attribution 4.0 International License.Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).